United Services Automobile Association’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-123,683
Closed -$1.15M 1536
2019
Q2
$1.15M Buy
123,683
+1,130
+0.9% +$8.24K ﹤0.01% 1267
2019
Q1
$643K Hold
122,553
﹤0.01% 1513
2018
Q4
$545K Sell
122,553
-4,110
-3% -$22.5K ﹤0.01% 1525
2018
Q3
$1.02M Hold
126,663
﹤0.01% 1345
2018
Q2
$889K Sell
126,663
-1,535
-1% -$15.1K ﹤0.01% 1418
2018
Q1
$1.82M Buy
128,198
+2,311
+2% +$24.5K ﹤0.01% 1152
2017
Q4
$1.1M Buy
125,887
+13,964
+12% +$138K ﹤0.01% 1199
2017
Q3
$1.31M Buy
111,923
+2,755
+3% +$33.8K ﹤0.01% 1149
2017
Q2
$1.52M Buy
109,168
+5,628
+5% +$64.3K ﹤0.01% 1103
2017
Q1
$1.42M Sell
103,540
-4,140
-4% -$43K ﹤0.01% 1054
2016
Q4
$772K Buy
107,680
+18,480
+21% +$203K ﹤0.01% 1144
2016
Q3
$1.35M Buy
89,200
+32,800
+58% +$431K ﹤0.01% 1063
2016
Q2
$556K Sell
56,400
-1,590
-3% -$21.8K ﹤0.01% 1149
2016
Q1
$772K Buy
+57,990
New +$729K ﹤0.01% 1099

Other funds holding SNDX

United Services Automobile Association's SNDX Position: Q3 2019 in Review

United Services Automobile Association sold out of Syndax Pharmaceuticals (SNDX) in Q3 2019, closing a stake of 123,683 shares — an estimated $1.15M sold.

United Services Automobile Association first reported a position in SNDX in Q1 2016 and held it in 14 quarters. The position peaked at $1.82M in Q1 2018. 72 funds tracked by Wall St. Rank hold SNDX as of Q3 2019.

  • United Services Automobile Association reported no remaining Syndax Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 123,683 Syndax Pharmaceuticals shares in Q3 2019, an estimated $1.15M.
  • United Services Automobile Association first reported a position in Syndax Pharmaceuticals in Q1 2016 and held it in 14 quarters.
  • United Services Automobile Association's Syndax Pharmaceuticals position peaked at $1.82M in Q1 2018.
  • 72 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.